换一批KRAS-mutant advanced NSCLC: efficacy and clinical outcomes from network meta-analysis and real-world evidence.
第一作者：
Xiaoyu,Gang
第一单位：
Department of Medical Oncology, The First Hospital of China Medical University, Shenyang 110001, China.
作者：
医学主题词
人类(Humans);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);肺肿瘤(Lung Neoplasms);原癌基因蛋白质类p21(ras)(Proto-Oncogene Proteins p21(ras));突变(Mutation);治疗结果(Treatment Outcome);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);随机对照试验(主题)(Randomized Controlled Trials as Topic);免疫疗法(Immunotherapy)
DOI
10.1016/j.lungcan.2026.108930
PMID
41544598
发布时间
2026-02-15
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
